"It is unrealistic to expect that COVID-19 pandemic can be eliminated at this stage given that community transmission is already well-established across large sections or sub-populations in the country," the report said.
I got to know that every referred case for angiography and angioplasty got a kickback of Rs 5,000 and Rs 15,000 respectively. Seeing this trend, doctors started paying referring doctors Rs 1 lakh in advance and adjusting it as and when patients came in. This menace slowly spread its tentacles all over the medical field, including radiological diagnostics and biochemistry laboratories. For every test ordered, 20 per cent of the bill was given back to the referring doctor. This led to doctors recommending unnecessary tests. The pharmaceutical companies also saw burgeoning business. Acclaimed doctors were given televisions sets, refrigerators, air conditioners and cars depending upon the prescriptions. General practitioners would prescribe unnecessary drugs, and were given returns in cash. A fascinating excerpt from Dr Upendra Kaul's When The Heart Speaks.
'Even if Serum Institute and Bharat Biotech were successful in ramping up production overnight, what happens to the capacity after the demand from India is met?' asks Sanjeev Nayyar.
Anti-inflammatory or immunomodulatory therapy, such as steroids, can have the risk of secondary infection like invasive mucormycosis, when used too early, at higher dose or for longer than required, they highlighted.
September witnessed 24,33,319 people recuperating from coronavirus infection contributing to around 46.15 per cent of the total 52,73,201 recoveries registered so far in the country.
The Congress leader from Gujarat said the Dalit community has given a call for a nationwide candle march on February 19 in support of Solanki, who was a first-year student of B.Tech (chemical) course.
Codeine-based formulations are under the scanner for misuse as a narcotic product.
'There is no data to show this virus is more deadlier.'
Bharat Biotech, Serum Institute, Zydus Cadila, Panacea Biotec, Indian Immunologicals, Mynvax and Biological E are among the domestic pharma firms working on the coronavirus vaccines in India.
While Ramdev claimed that Ayurved-based 'Coronil and Swasari' medicine have shown 100 per cent favourable results during clinical trials on COVID-19 infected patients except those on a life support system, the Ayush Ministry sought from the company detailed report on composition, testing and other data of the drugs.
The phase 3 trial is being implemented as part of Operation Warp Speed, a multi-agency collaboration led by the US Health and Human Services, which aims at accelerating the development and manufacturing of medical countermeasures for COVID-19 and delivering 300 million doses of an effective vaccine by January 2021.
Experts say herd immunity is said to have been developed in a population segment if at least 50-60 per cent of those are found to have the presence of antibodies in a sero-prevalence survey.
'When I was toying with 10 different ideas, my father was diagnosed with lung fibrosis and his condition deteriorated so badly that we lost him in six months. He was very unsatisfied with the lack of proper diagnosis.' 'It made me think will anyone do a biopsy if there is no symptom? Why is it that we do not have any non-invasive diagnostic method?' 'This idea was the strongest out of the ten, and with Snahlata Singh with her cancer biology background joining me, the idea got a real boost.'
The Indian government and private firms have stepped up efforts to develop a vaccine to halt the spread of COVID-19 which has claimed over 3,700 lives with more than 1,25,000 cases in the country.
Zydus Cadila COVID-19 vaccine for children above 12 years is expected to be available by August as its trials are likely to be completed by July-end, said Dr N K Arora, Chairman, National Technical Advisory Group on Immunisation (NTAGI).
Why did the Chinese military take over the lab in Wuhan in end January? Did something go wrong? Claude Arpi glances at the mystery surrounding the origin of the coronavirus.
As India prepares to launch its vaccine drive on January 16, here is a look at the options:
The number of active cases has reduced to 17,13,413, accounting for 6.02 per cent of the total number of cases.
'We need to prove to the world that quality vaccines and R&D are possible in India.'
This is the second day in a row that the case positivity rate has remained below 10 per cent, the ministry said. The weekly positivity rate has also declined to 11.45 per cent.
The NTAGI has also stated that those having laboratory test proven SARS-CoV-2 illness should defer COVID-19 vaccination for six months after recovery, the sources said.
The American Association of Physicians of Indian Origin will attend the Pravasi Bharatiya Divas in Delhi with an agenda to develop a plan to bring together AAPI, NGOs and the government to provide access to affordable and quality health care. Aziz Haniffa reports
The female tiger, named Nadia, is believed to be the first known case of an animal infected with COVID-19 in the US. It is suspected that she contracted the virus from a caretaker who was asymptomatic at that time.
Experts said the strain has not propelled a surge in cases like Omicron, but advised strict adherence to COVID-19-appropriate behaviour.
"The licence for the drug was obtained on the basis of the traditional knowledge and experience related to the medicinal virtues of Ashwagandha, Giloy and Tulsi," Patanjali spokesperson S K Tijarawala said.
Breast cancer is on the rise even among women in their early 30s.
'Time is of the essence in a quarantine situation, perhaps the best way in the present unprecedented situation to balance conflicting interests between individual's rights and public health is to allow for immediate quarantine for preventing spread of contagious and infectious COVID-19'
It is the first time that the JMI has been placed among the top 10 universities in the (HRD) Ministry's National Institutional Ranking Framework rankings.
Tests conducted on disgraced Pakistan nuclear scientist A Q Khan, who is suffering from prostrate cancer, have found that he is out of danger, officials in Islamabad said.
'I feel she has some mental disorder. Or, it was an act of pure revenge.'
The health ID will contain information about medical data, prescriptions and diagnostic reports and summaries of previous discharge from hospitals for ailments. The mission is expected to bring efficiency and transparency in healthcare services in the country.
Rs 7,774 crore, has been provisioned for COVID-19 Emergency Response and the rest for medium-term support, ranging from one to four years to be provided under mission-mode approach.
Hospitals to recover from sluggish Q3; diagnostics' growth rate at pre-Covid levels.
The co-lead author of the study, Indian-origin surgeon Aneel Bhangu from the University of Birmingham, said the study was aimed at improving our understanding of the deadly virus.
'They (the ransomware attackers) are not after any VVIP data.' 'Had that been the case, they would have quietly installed a different malware.'
The Union health ministry said West Bengal and Himachal Pradesh reported a casualty each on Monday, taking the total number of deaths to nine in the country due to COVID-19.
The first nationwide mock drill was held on January 2 which, the health ministry said, helped to iron out any glitches in the final execution and further refinement of the operational procedures.
The complaint seeking registration of a first information report on cheating, criminal conspiracy and other charges was filed in the court of Chief Judicial Magistrate Mukesh Kumar here on Tuesday by Tamanna Hashmi, who identifies himself as a social worker and is often in news for his numerous court complaints against politicians over various issues.
India's COVID-19 recovery rate rose to 63.13 per cent on Wednesday with a record 28,472 patients recuperating from the disease in 24 hours, while the case fatality rate further dropped to 2.41 per cent, the Union health ministry said.
India is the fourth worst-hit nation by the pandemic after the United States, Brazil and Russia.